California State Teachers Retirement System (CalSTRS)’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.8K Sell
1,285
-3,680
-74% -$16.4K ﹤0.01% 2423
2026
Q1
$18.6K Sell
4,965
-684
-12% -$2.31K ﹤0.01% 2469
2025
Q4
$17K Sell
5,649
-19
-0.3% -$48 ﹤0.01% 2585
2025
Q3
$10.8K Buy
5,668
+4
+0.1% +$7 ﹤0.01% 2806
2025
Q2
$8.04K Buy
+5,664
New +$7.67K ﹤0.01% 2809
2024
Q2
Sell
-6,982
Closed -$8.66K 3087
2024
Q1
$8.66K Sell
6,982
-48,577
-87% -$57.9K ﹤0.01% 2936
2023
Q4
$58.3K Sell
55,559
-3,488
-6% -$10.6K ﹤0.01% 2560
2023
Q3
$404K Sell
59,047
-8,054
-12% -$68.8K ﹤0.01% 2306
2023
Q2
$696K Buy
67,101
+2,076
+3% +$18.8K ﹤0.01% 2132
2023
Q1
$526K Sell
65,025
-1,299
-2% -$16.5K ﹤0.01% 2285
2022
Q4
$1.04M Buy
66,324
+708
+1% +$11.4K ﹤0.01% 1866
2022
Q3
$1.03M Buy
65,616
+3,618
+6% +$57K ﹤0.01% 1867
2022
Q2
$865K Buy
61,998
+1,012
+2% +$14.2K ﹤0.01% 2056
2022
Q1
$1.05M Sell
60,986
-5,474
-8% -$74.7K ﹤0.01% 2007
2021
Q4
$966K Buy
66,460
+2,639
+4% +$40K ﹤0.01% 2180
2021
Q3
$1.15M Buy
63,821
+3,925
+7% +$62.9K ﹤0.01% 2055
2021
Q2
$1.05M Buy
+59,896
New +$1.36M ﹤0.01% 2185
2020
Q2
Sell
-47,336
Closed -$49K 3020
2020
Q1
$49K Buy
47,336
+549
+1% +$747 ﹤0.01% 2916
2019
Q4
$88K Sell
46,787
-653
-1% -$1.08K ﹤0.01% 2938
2019
Q3
$51K Hold
47,440
﹤0.01% 2988
2019
Q2
$104K Sell
47,440
-7,973
-14% -$43.5K ﹤0.01% 2977
2019
Q1
$332K Hold
55,413
﹤0.01% 2532
2018
Q4
$410K Buy
55,413
+14,509
+35% +$150K ﹤0.01% 2404
2018
Q3
$594K Sell
40,904
-3
-0% -$51 ﹤0.01% 2356
2018
Q2
$817K Buy
40,907
+5,643
+16% +$104K ﹤0.01% 2180
2018
Q1
$618K Sell
35,264
-1,381
-4% -$29.3K ﹤0.01% 2263
2017
Q4
$904K Buy
36,645
+587
+2% +$14.3K ﹤0.01% 2060
2017
Q3
$931K Buy
36,058
+362
+1% +$9.7K ﹤0.01% 2049
2017
Q2
$968K Buy
35,696
+13,500
+61% +$367K ﹤0.01% 2082
2017
Q1
$662K Sell
22,196
-1,100
-5% -$31.7K ﹤0.01% 2322
2016
Q4
$632K Buy
23,296
+3,200
+16% +$81.6K ﹤0.01% 2392
2016
Q3
$515K Buy
20,096
+1,200
+6% +$25.5K ﹤0.01% 2480
2016
Q2
$349K Buy
18,896
+6,683
+55% +$132K ﹤0.01% 2664
2016
Q1
$231K Buy
12,213
+1,563
+15% +$29.9K ﹤0.01% 2767
2015
Q4
$287K Buy
+10,650
New +$207K ﹤0.01% 2730

Other funds holding ACRS

California State Teachers Retirement System (CalSTRS)'s ACRS Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Aclaris Therapeutics (ACRS) stake by 74% in Q2 2026, selling an estimated $16.4K and leaving 1,285 shares worth $6.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2423.

California State Teachers Retirement System (CalSTRS) first reported a position in ACRS in Q4 2015 and has held it in 35 quarters since. The position peaked at $1.15M in Q3 2021. 149 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 1,285 shares of Aclaris Therapeutics worth $6.8K as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 3,680 Aclaris Therapeutics shares in Q2 2026, an estimated $16.4K.
  • Aclaris Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2423 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Aclaris Therapeutics in Q4 2015 and has held it in 35 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Aclaris Therapeutics position peaked at $1.15M in Q3 2021.
  • 149 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.